Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2017

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

Presenter: Shigeru Saito, Jonathon M. White, Johannes Brechtken, MD

June 16, 2017

Presentation TVT 2017

Case Presentation: A Case of Valve-in-Valve TAVR in a Stentless Bioprosthesis

Presenter: Molly Szerlip

June 15, 2017

Presentation TVT 2016

TVT 1135: Transcatheter Aortic Valve Replacement With CoreValve Supported With a Palmaz Stent in a High-Risk Patient With Severe Aortic Insufficiency

Presenter: Abdulfattah Saidi, MD

June 17, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Presentation TVT 2014

Ad Hoc TAVI, Coronary Stenting, and LAA Closure

Presenter: Fabian Nietlispach

June 07, 2014

Presentation TVT 2013

Ad-hoc TAVI, Ad-hoc Coronary Stenting, and Ad-hoc LAA Closure

Presenter: Fabian Nietlispach

June 13, 2013

Advertisement

More Support for Single Antiplatelet Therapy After TAVI

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

Case Presentation: A Case of Valve-in-Valve TAVR in a Stentless Bioprosthesis

TVT 1135: Transcatheter Aortic Valve Replacement With CoreValve Supported With a Palmaz Stent in a High-Risk Patient With Severe Aortic Insufficiency

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Ad Hoc TAVI, Coronary Stenting, and LAA Closure

Ad-hoc TAVI, Ad-hoc Coronary Stenting, and Ad-hoc LAA Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content